Skip to main content

Jury Selection Over Bard’s First TVM Lawsuit

Jury Selection Over Bard’s First TVM Lawsuit

Jury Selection Over Bard’s First TVM Lawsuit

Introduction

C.R. Bard, Inc. will face its first transvaginal mesh lawsuit in New Jersey before Bergen County Superior Court Judge James DeLuca. The Plaintiff is a woman who received Bard’s TVM implants to treat Pelvic Organ Prolapse (“POP”) or Stress. Urinary Incontinence that left her suffering from chronic pain. She holds Bard responsible, claiming the devices were defectively designed and manufactured.

Two cases have previously gone to trial in New Jersey, but both cases involved implants manufactured by J&J subsidiary Ethicon. Roughly 160 cases are pending that involve Bard’s implants. Since the first trial in 2012, only three cases involved C.R. Bard implants, out of which two verdicts went in favor of the plaintiff totaling to nearly $7.5 million and the third verdict was announced in favor of the defense.

Hundreds of transvaginal mesh lawsuits have been roped into confidential settlement agreements in recent years by C.R. Bard.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.